Testing effectiveness (Phase 2)Looking for participantsNCT06226883
What this trial is testing
Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Who this might be right for
Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) 385